MiMedx Group, Inc. Total Assets
MiMedx Group, Inc. (MDXG) had Total Assets of $281.00 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-07-29
- 2026-06-30: Assets $281.00M.
- 2026-03-31: Assets $308.68M.
- 2025-12-31: Assets $342.65M.
- 2025-09-30: Assets $318.99M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $281.00M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $308.68M 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $342.65M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $318.99M 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $291.11M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $270.42M 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $263.92M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $243.89M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $230.18M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $221.68M 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $239.05M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $189.02M 10-Q · filed 2023-10-30 | |
| 2023-06-30 | $176.38M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $168.16M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $171.43M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $172.80M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $168.67M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $174.44M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $187.93M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $180.52M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $187.15M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $190.81M 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $202.03M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $213.32M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $150.91M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $158.91M 10-Q · filed 2020-07-06 | |
| 2019-12-31 | $167.17M 10-K · filed 2021-03-08 | |
| 2019-09-30 | $179.27M 10-Q · filed 2020-07-06 | |
| 2019-06-30 | $170.31M 10-Q · filed 2020-07-06 | |
| 2019-03-31 | $107.44M 10-Q · filed 2020-07-06 | |
| 2018-12-31 | $122.84M 10-K · filed 2020-07-06 | |
| 2017-12-31 | $121.25M 10-K · filed 2020-03-17 | |
| 2017-09-30 | $178.71M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $199.87M 10-Q · filed 2017-07-31 | |
| 2017-03-31 | $188.49M 10-Q · filed 2017-05-01 | |
| 2016-12-31 | $117.27M 10-K · filed 2020-03-17 | $193.26M 10-K · filed 2017-03-01 |
| 2016-09-30 | $181.66M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $177.06M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $177.22M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $135.91M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $125.93M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $113.84M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $106.11M 10-Q · filed 2015-05-01 | |
| 2014-12-31 | $109.26M 10-K · filed 2017-02-22 | |
| 2014-09-30 | $97.32M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $86.02M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $87.35M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $84.69M 10-K · filed 2015-03-13 | $84.69M 10-K · filed 2014-03-04 |
| 2013-09-30 | $45.30M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $40.28M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $37.85M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $35.18M 10-K · filed 2014-03-04 | |
| 2012-09-30 | $33.54M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $27.47M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $26.86M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $27.10M 10-K · filed 2013-03-15 | |
| 2011-09-30 | $23.55M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $24.28M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $7.35M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |